Table Of Content

international journal of pharmaceutics 4 aX HH ELSEVIER International Journal of Pharmaceutics 140 (1996) 259—260 Author index Abi Khalil, F., M. Van Damme, M. Hanocgq, P. Mauriac, J. Darwish, I.A., see El-Massik, M.A. 140, 69 Saint-Germain, D. Bouzard, J.F. Dauphin, Simultaneous Dauphin, J.F., see Abi Khalil, F. 140, | determination of the ionisation and dimerization constants Delgado, A., C. Evora, M. Llabres, Degradation of DL-PLA- and the partition and ion pair extraction coefficients for 1-8 methadone microspheres during in vitro release 140, 219 naphtyridine derivatives 140, | Dhodi, N., see Menon, A. 140, 207 Abrahamsson, B., M. Alpsten, U.E. Jonsson, P.J. Lundberg, El-Khordagui, L.K., see Darwish, I.A. 140, 25 A. Sandberg, M. Sundgren, A. Svenheden, J. TOolli, Gastro- El-Khordagui, L.K., see El-Massik, M.A. 140, 69 intestinal transit of a multiple-unit formulation (metoprolol El-Massik, M.A., I.A. Darwish, E.E. Hassan, L.K. El- CR/ZOK) and a non-disintegrating tablet with the emphasis Khordagui, Development of a dissolution medium for on colon 140, 229 glibenclamide 140, 69 Ademola, J.I., see Montenegro, L. 140, 51 El-Massik, M.A., see Darwish, I.A. 140, 25 Adjei, A., see Gupta, P. 140, 119 Estes, K.S., see Pop, E. 140, 33 Alpsten, M., see Abrahamsson, B. 140, 229 Evora, C., see Delgado, A. 140, 219 Amidon, G.L., see Yu, L.X. 140, 111 Anderson, W.R., see Pop, E. 140, 33 Faroongsarng, D., see Mitrevej, A. 140, 61 Ferrier, D., see Sarbach, C. 140, 169 Barzegar-Jalali, M., A. Jouyban-Gharamaleki, Models for cal- Ford, J.L., see Dabbagh, M.A. 140, 85 culating solubility in binary solvent systems 140, 237 Bauer-Brandl, A., Polymorphic transitions of cimetidine dur- Gizurarson, S., T. Thorvaldsson, P. Sigurdsson, E. Gun- ing manufacture of solid dosage forms 140, 195 narsson, Selective delivery of insulin into the brain: intraol- Baykara, T., see Yiiksel, N. 140, 145 factory absorption 140, 77 Bodor, N.S., see Pop, E. 140, 33 Gullapalli, R.P., B.B. Sheth, Effect of methylcellulose on the Bolhuis, G.K., see van der Voort Maarschalk, K. 140, 185 stability of oil-in-water emulsions 140, 97 Bonina, F.P., see Montenegro, L. 140, 51 Gunnarsson, E., see Gizurarson, S. 140, 77 Bouzard, D., see Abi Khalil, F. 140, | Gupta, P., J. Cannon, A. Adjei, Liposomal formulations of Brewster, M.E., see Pop, E. 140, 33 ABT-077: In vitro characterization studies 140, 119 Cadorniga, R., see Torrado, S. 140, 247 Hanocq, M., see Abi Khalil, F. 140, 1 Cadorniga, R., see Torrado, S. 140, 45 Hassan, E.E., see Darwish, 1.A. 140, 25 Cannon, J., see Gupta, P. 140, 119 Hassan, E.E., see El-Massik, M.A. 140, 69 Chakrabarti, S., see Menon, A. 140, 207 Hogan, J.E., see Dabbagh, M.A. 140, 85 Crison, J.R., see Yu, L.X. 140, 111 Hsu, C.C., see Maa, Y.-F. 140, 155 Dabbagh, M.A., J.L. Ford, M.H. Rubinstein, J.E. Hogan, Irwin, W.J., see Nicklin, P.L. 140, 175 Effects of polymer particle size, compaction pressure and hydrophilic polymers on drug release from matrices contain- Jonsson, U.E., see Abrahamsson, B. 140, 229 ing ethylcellulose 140, 85 Jouyban-Gharamaleki, A., see Barzegar-Jalali, M. 140, 237 Darwish, I.A., M.A. El-Massik, E.E. Hassan, L.K. El- Khordagui, Assessment of a hydroalcoholic surfactant solu- Khan, M.Z.I., Dissolution testing for sustained or controlled tion as a medium for the dissolution testing of release oral dosage forms and correlation with in vivo data: phenytoin 140, 25 challenges and opportunities 140, 131 260 Author index Leon, M.J., see Lucero, M.J. 140, 251 Sarbach, C., N. Yagoubi, J. Sauzieres, C. Renaux, D. Ferrier, Lerk, C.F., see van der Voort Maarschalk, K. 140, 185 E. Postaire, Migration of impurities from a multilayer plas- Llabres, M., see Delgado, A. 140, 219 tics container into a parenteral infusion fluid 140, 169 Lucero, M.J., J. Vigo, M.J. Leon, Degradation kinetics of Sauzieres, J., see Sarbach, C. 140, 169 a-tocopherol in hydrophilic gels 140, 251 Sheth, B.B., see Gullapalli, R.P. 140, 97 Lundberg, P.J., see Abrahamsson, B. 140, 229 Sigurdsson, P., see Gizurarson, S. 140, 77 Sinchaipanid, N., see Mitrevej, A. 140, 61 Maa, Y.-F., C.C. Hsu, Aggregation of recombinant human Soti, F., see Pop, E. 140, 33 growth hormone induced by phenolic compounds 140, 155 Sundgren, M., see Abrahamsson, B. 140, 229 Maibach, H.I., see Montenegro, L. 140, 51 Svenheden, A., see Abrahamsson, B. 140, 229 Mandella, W., see Menon, A. 140, 207 Thorvaldsson, T., see Gizurarson, S. 140, 77 Mauriac, P., see Abi Khalil, F. 140, | Timmins, P., see Nicklin, P.L. 140, 175 Menon, A., N. Dhodi, W. Mandella, S. Chakrabarti, Identify- Tinger, T., see Yiiksel, N. 140, 145 ing fluid-bed parameters affecting product variability 140, TOlli, J., see Abrahamsson, B. 140, 229 207 Torrado, J.J., see Torrado, S. 140, 247 Mitrevej, A., D. Faroongsarng, N. Sinchaipanid, Compression Torrado, J.J., see Torrado, S. 140, 45 behavior of spray dried rice starch 140, 61 Torrado, S., see Torrado, S. 140, 247 Montenegro, L., J.1. Ademola, F.P. Bonina, H.I. Maibach, Torrado, S., see Torrado, S. 140, 45 Effect of application time of betamethasone-17-valerate Torrado, S., S. Torrado, J.J. Torrado, R. Cadorniga, Prepara- 0.1% cream on skin blanching and stratum corneum drug tion, dissolution and characterization of albendazole solid concentration 140, 51 dispersions 140, 247 Morrison, R.A., see Nicklin, P.L. 140, 175 Torrado, S., S. Torrado, R. Cadorniga, J.J. Torrado, Formu- Miller, R.H., see Zingel, C. 140, 13 lation parameters of albendazole solution 140, 45 Nicklin, P.L., W.J. Irwin, P. Timmins, R.A. Morrison, Uptake Van Damme, M., see Abi Khalil, F. 140, | and transport of the ACE-inhibitor ceronapril (SQ 29852) van der Voort Maarschalk, K., K. Zuurman, H. Vromans, by monolayers of human intestinal absorptive (Caco-2) cells G.K. Bolhuis, C.F. Lerk, Porosity expansion of tablets as a in vitro 140, 175 result of bonding and deformation of particulate solids 140, 185 Panetta, J.A., see Pop, E. 140, 33 Vigo, J., see Lucero, M.J. 140, 251 Pop, E., F. Soti, W.R. Anderson, J.A. Panetta, K.S. Estes, Vromans, H., see van der Voort Maarschalk, K. 140, 185 N.S. Bodor, M.E. Brewster, Redox targeting of LY231617, Yagoubi, N., see Sarbach, C. 140, 169 an antioxidant with potential use in the treatment of brain Yiiksel, N., T. Tinger, T. Baykara, Interaction between damage 140, 33 nicardipine hydrochloride and polymeric microspheres for a Postaire, E., see Sarbach, C. 140, 169 controlled release system 140, 145 Yu, L.X., J.R. Crison, G.L. Amidon, Compartmental transit Renaux, C., see Sarbach, C. 140, 169 and dispersion model analysis of small intestinal transit flow ROBling, G.L., see Zingel, C. 140, 13 in humans 140, 111 Rubinstein, M.H., see Dabbagh, M.A. 140, 85 Zingel, C., A. Sachse, G.L. R6Bling, R.H. Miller, Lyophiliza- Sachse, A., see Zingel, C. 140, 13 tion and rehydration of iopromide-carrying liposomes 140, Saint-Germain, J., see Abi Khalil, F. 140, | 13 Sandberg, A., see Abrahamsson, B. 140, 229 Zuurman, K., see van der Voort Maarschalk, K.V. 140, 185